Literature DB >> 22086829

Insanity of left ventricular assist therapy: doing the same thing and expecting different results.

James F Antaki.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 22086829      PMCID： PMC3249755          DOI： 10.1161/CIRCHEARTFAILURE.111.964650

Source DB:  PubMed          Journal:  Circ Heart Fail        ISSN： 1941-3289            Impact factor:   8.790


× No keyword cloud information.
  5 in total

1.  The REMATCH trial: rationale, design, and end points. Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure.

Authors:  E A Rose; A J Moskowitz; M Packer; J A Sollano; D L Williams; A R Tierney; D F Heitjan; P Meier; D D Ascheim; R G Levitan; A D Weinberg; L W Stevenson; P A Shapiro; R M Lazar; J T Watson; D J Goldstein; A C Gelijns
Journal:  Ann Thorac Surg       Date:  1999-03       Impact factor: 4.330

2.  The total artificial heart.

Authors:  R K Jarvik
Journal:  Sci Am       Date:  1981-01       Impact factor: 2.142

3.  Development of a hybrid decision support model for optimal ventricular assist device weaning.

Authors:  Linda C Santelices; Yajuan Wang; Don Severyn; Marek J Druzdzel; Robert L Kormos; James F Antaki
Journal:  Ann Thorac Surg       Date:  2010-09       Impact factor: 4.330

Review 4.  Patient-reported outcomes in left ventricular assist device therapy: a systematic review and recommendations for clinical research and practice.

Authors:  Corline Brouwers; Johan Denollet; Nicolaas de Jonge; Kadir Caliskan; Jennifer Kealy; Susanne S Pedersen
Journal:  Circ Heart Fail       Date:  2011-09-09       Impact factor: 8.790

5.  Chronic mechanical circulatory support for inotrope-dependent heart failure patients who are not transplant candidates: results of the INTrEPID Trial.

Authors:  Joseph G Rogers; Javed Butler; Steven L Lansman; Alan Gass; Peer M Portner; Michael K Pasque; Richard N Pierson
Journal:  J Am Coll Cardiol       Date:  2007-08-06       Impact factor: 24.094
  5 in total
  1 in total

1.  Galectin-3 and ST2 as predictors of therapeutic success in high-risk patients undergoing percutaneous mitral valve repair (MitraClip).

Authors:  Oliver Dörr; Claudia Walther; Christoph Liebetrau; Till Keller; Thomas Sommer; Niklas Boeder; Matthias Bayer; Pascal Bauer; Helge Möllmann; Luise Gaede; Christian Troidl; Sandra Voss; Timm Bauer; Christian W Hamm; Holger Nef
Journal:  Clin Cardiol       Date:  2018-08-20       Impact factor: 2.882
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.